Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. (Q47963971)

7 February 2018

meta-analysis

0 references

title

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. (English)

1 reference

7 February 2018

2

Geoffrey Donnan

1 reference

7 February 2018

4

Markku Kaste

1 reference

7 February 2018

7

Thomas Brott

1 reference

7 February 2018

Cesare Fieschi

3

object named as

Cesare Fieschi

1 reference

7 February 2018

James C Grotta

9

object named as

James C Grotta

1 reference

7 February 2018

author name string

Werner Hacke

1

1 reference

7 February 2018

Rüdiger von Kummer

5

1 reference

7 February 2018

Joseph P Broderick

6

1 reference

7 February 2018

Michael Frankel

8

1 reference

7 February 2018

E Clarke Haley

10

1 reference

7 February 2018

Thomas Kwiatkowski

11

1 reference

7 February 2018

Steven R Levine

12

1 reference

7 February 2018

Chris Lewandowski

13

1 reference

7 February 2018

Mei Lu

14

1 reference

7 February 2018

Patrick Lyden

15

1 reference

7 February 2018

John R Marler

16

1 reference

7 February 2018

Suresh Patel

17

1 reference

7 February 2018

Barbara C Tilley

18

1 reference

7 February 2018

Gregory Albers

19

1 reference

7 February 2018

Erich Bluhmki

20

1 reference

7 February 2018

Manfred Wilhelm

21

1 reference

7 February 2018

Scott Hamilton

22

1 reference

7 February 2018

ATLANTIS Trials Investigators

23

1 reference

7 February 2018

ECASS Trials Investigators

24

1 reference

7 February 2018

NINDS rt-PA Study Group Investigators

25

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

7 February 2018

published in

The Lancet

1 reference

7 February 2018

volume

363

1 reference

7 February 2018

issue

9411

1 reference

7 February 2018

page(s)

768-774

1 reference

7 February 2018

Tissue plasminogen activator for acute ischemic stroke

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Observer variability in assessing impaired consciousness and coma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915692-4

7 January 2021

10.1016/S0140-6736(04)15692-4

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

15016487

1 reference

7 February 2018